Bad Blood

Secrets and Lies in a Silicon Valley Startup

John Carreyrou

Publisher: Knopf, 2018, 339 pages

ISBN: 978-1-5247-1148-1

Keywords: Biography

Last modified: Sept. 19, 2019, 9:18 p.m.

Bad Blood is the full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prizewinning journalist who first broke the story and pursued it to the end, despite pressure from Theranos's charismatic CEO and threats by her lawyers.

In 2015, Theranos founder and CEO Elizaeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by big-player investors, Theranos sold shares in a fund-raising round that valued the company at more than $9 billion, puttingh Holmes's worth at an estimated $4.5 billion. There was just one problem: the technology didn't work.

This is a gripping story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises and gold-rush frenzy of Silicon Valley.

  1. A Purposeful Life
  2. The Gluebot
  3. Apple Envy
  4. Goodbye East Paly
  5. The Childhood Neighbor
  6. Sunny
  7. Dr. J
  8. The Minilab
  9. The Wellness Play
  10. "Who Is LTC Shoemaker?"
  11. Lighting a Fuisz
  12. Ian Gibbons
  13. Chiat\Day
  14. Going Live
  15. Unicorn
  16. The Grandson
  17. Fame
  18. The Hippocratic Oath
  19. The Tip
  20. The Ambush
  21. Trade Secrets
  22. La Mattanza
  23. Damage Control
  24. The Empress Has No Clothes

Reviews

Bad Blood

Reviewed by Roland Buresund

Very Good ******** (8 out of 10)

Last modified: Sept. 18, 2019, 10:57 a.m.

A very good and in-depth description of the rise and fall of Theranos.

The only thing that stops this from getting a higher rating, is that the author fails to get under skin of the management team members, except to make them feel extremely odd (but no real explanation on why).

Recommended reading.

Comments

There are currently no comments

New Comment

required

required (not published)

optional

required

captcha

required